Market Overview

Jefferies Downgrades Regeneron Pharmaceuticals, Inc. to Hold, Maintains $179.00 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for REGN

DateFirmActionFromTo
Feb 2016BarclaysMaintainsEqual-weight
Feb 2016Brean CapitalMaintainsBuy
Feb 2016UBSMaintainsBuy

View More Analyst Ratings for REGN
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (REGN)

Get Benzinga's Newsletters